Striving for Carbon Footprint Benchmarks
Insights from recent industry events clear path for companies to identify how their internal practices could be harming the environment.
Earlier in the year, I wrote about
To that end, Janssen’s Clinical Innovation Team presented its own carbon footprint contributors at the Clinical Trials Europe 2022 Informa event six months ago, with the following
It is this ability to measure and quantify that companies can initiate their journey for change with informed benchmarks. Such is the goal of the
This ability to turn on and off parameters makes it important to understand the unintended consequences of choices. For example, while DCTs may be desirable from a “patient journey” aspect of getting to and from a site, the downstream effect of drug delivery to the home could include emissions in the form of transportation, as well as eco-insufficient packaging choices.
At the Pharma 2023 Reuters event in April, a panel discussed this very conundrum. With the focus on climate change, one expert warned “If we change something, we need to ensure that we are not going to degrade the environment in another way.”
Panelists also discussed where companies should start their efforts, and all agreed: it starts with commitment, collective action, and a collaborative effort to share progress and standards.
Articles in this issue
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.